Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23995608 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy
Condition: Acute Coronary Syndrome
Interventions: Drug: Otamixaban (XRP0673);   Drug: Otamixaban matching placebo;   Drug: Unfractionated Heparin;   Drug: Unfractionated Heparin matching placebo;   Drug: Eptifibatide;   Drug: Eptifibatide matching placebo

Indicates status has not been verified in more than two years